LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC

Aberrant expression of lysyl oxidase-like 1 (LOXL1) reportedly leads to fibrous diseases. Recent studies have revealed its role in cancers. In this study, we observed an elevated level of LOXL1 in the tissues and sera of patients with intrahepatic cholangiocarcinoma (ICC) compared with levels in non...

Full description

Bibliographic Details
Main Authors: Ruiyan Yuan, Yang Li, Bo Yang, Zhaohui Jin, Jiacheng Xu, Ziyu Shao, Huijie Miao, Tai Ren, Yang Yang, Guoqiang Li, Xiaoling Song, Yunping Hu, Xu’an Wang, Ying Huang, Yingbin Liu
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253121000019
_version_ 1818616643000991744
author Ruiyan Yuan
Yang Li
Bo Yang
Zhaohui Jin
Jiacheng Xu
Ziyu Shao
Huijie Miao
Tai Ren
Yang Yang
Guoqiang Li
Xiaoling Song
Yunping Hu
Xu’an Wang
Ying Huang
Yingbin Liu
author_facet Ruiyan Yuan
Yang Li
Bo Yang
Zhaohui Jin
Jiacheng Xu
Ziyu Shao
Huijie Miao
Tai Ren
Yang Yang
Guoqiang Li
Xiaoling Song
Yunping Hu
Xu’an Wang
Ying Huang
Yingbin Liu
author_sort Ruiyan Yuan
collection DOAJ
description Aberrant expression of lysyl oxidase-like 1 (LOXL1) reportedly leads to fibrous diseases. Recent studies have revealed its role in cancers. In this study, we observed an elevated level of LOXL1 in the tissues and sera of patients with intrahepatic cholangiocarcinoma (ICC) compared with levels in nontumor tissues and sera of unaffected individuals. Overexpression of LOXL1 in RBE and 9810 cell lines promoted cell proliferation, colony formation, and metastasis in vivo and in vitro and induced angiogenesis. In contrast, depletion of LOXL1 showed the opposite effects. We further showed that LOXL1 interacted with fibulin 5 (FBLN5), which regulates angiogenesis, through binding to the αvβ3 integrin in an arginine-glycine-aspartic (Arg-Gly-Asp) domain-dependent mechanism and enhanced the focal adhesion kinase (FAK)-mitogen-activated protein kinase (MAPK) signaling pathway inside vascular endothelial cells. Our findings shed light on the molecular mechanism underlying LOXL1 regulation of angiogenesis in ICC development and indicate that the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis might be the critical pathological link leading to angiogenesis in ICC.
first_indexed 2024-12-16T16:53:03Z
format Article
id doaj.art-a1847a6aa2f1499fac7047d5e3741897
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-16T16:53:03Z
publishDate 2021-03-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-a1847a6aa2f1499fac7047d5e37418972022-12-21T22:23:58ZengElsevierMolecular Therapy: Nucleic Acids2162-25312021-03-0123797810LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICCRuiyan Yuan0Yang Li1Bo Yang2Zhaohui Jin3Jiacheng Xu4Ziyu Shao5Huijie Miao6Tai Ren7Yang Yang8Guoqiang Li9Xiaoling Song10Yunping Hu11Xu’an Wang12Ying Huang13Yingbin Liu14State Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaKey Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, Department of Surgery, First Affiliated Hospital of Wenzhou Medical University, Baixiang Road, Wenzhou 325000, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaEndoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaState Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaDepartment of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China; Corresponding author: Xu’an Wang, Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China.State Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China; Corresponding author: Ying Huang, State Key Laboratory of Oncogenes and Related Genes, Department of General Surgery, Shanghai Key Laboratory of Biliary Tract Disease Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China; Corresponding author: Yingbin Liu, Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China.Aberrant expression of lysyl oxidase-like 1 (LOXL1) reportedly leads to fibrous diseases. Recent studies have revealed its role in cancers. In this study, we observed an elevated level of LOXL1 in the tissues and sera of patients with intrahepatic cholangiocarcinoma (ICC) compared with levels in nontumor tissues and sera of unaffected individuals. Overexpression of LOXL1 in RBE and 9810 cell lines promoted cell proliferation, colony formation, and metastasis in vivo and in vitro and induced angiogenesis. In contrast, depletion of LOXL1 showed the opposite effects. We further showed that LOXL1 interacted with fibulin 5 (FBLN5), which regulates angiogenesis, through binding to the αvβ3 integrin in an arginine-glycine-aspartic (Arg-Gly-Asp) domain-dependent mechanism and enhanced the focal adhesion kinase (FAK)-mitogen-activated protein kinase (MAPK) signaling pathway inside vascular endothelial cells. Our findings shed light on the molecular mechanism underlying LOXL1 regulation of angiogenesis in ICC development and indicate that the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis might be the critical pathological link leading to angiogenesis in ICC.http://www.sciencedirect.com/science/article/pii/S2162253121000019angiogenesisintrahepatic cholangiocarcinomalysyl oxidase-like 1vascular endothelial celltumorigenesisLOXL1
spellingShingle Ruiyan Yuan
Yang Li
Bo Yang
Zhaohui Jin
Jiacheng Xu
Ziyu Shao
Huijie Miao
Tai Ren
Yang Yang
Guoqiang Li
Xiaoling Song
Yunping Hu
Xu’an Wang
Ying Huang
Yingbin Liu
LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
Molecular Therapy: Nucleic Acids
angiogenesis
intrahepatic cholangiocarcinoma
lysyl oxidase-like 1
vascular endothelial cell
tumorigenesis
LOXL1
title LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
title_full LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
title_fullStr LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
title_full_unstemmed LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
title_short LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC
title_sort loxl1 exerts oncogenesis and stimulates angiogenesis through the loxl1 fbln5 αvβ3 integrin fak mapk axis in icc
topic angiogenesis
intrahepatic cholangiocarcinoma
lysyl oxidase-like 1
vascular endothelial cell
tumorigenesis
LOXL1
url http://www.sciencedirect.com/science/article/pii/S2162253121000019
work_keys_str_mv AT ruiyanyuan loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT yangli loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT boyang loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT zhaohuijin loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT jiachengxu loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT ziyushao loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT huijiemiao loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT tairen loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT yangyang loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT guoqiangli loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT xiaolingsong loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT yunpinghu loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT xuanwang loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT yinghuang loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc
AT yingbinliu loxl1exertsoncogenesisandstimulatesangiogenesisthroughtheloxl1fbln5avb3integrinfakmapkaxisinicc